Drawing for Serial No. 79439554

USPTO serial 79439554

Serial No. 79439554

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
BECHHOFER, YOCHEVED D
Law office
TMO LAW OFFICE 137

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with Serial No. 79439554?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D. Hyra

Clifford D. Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treating neurological disorders, neurodegenerative diseases, eye diseases and conditions, bone disorders and conditions, retinal disorders and ocular diseases; pharmaceuticals and medicines for the treatment and prevention of neurological disorders; pharmaceuticals and medicines for the treatment and prevention of neurodegenerative diseases; pharmaceutical preparations and substances for the treatment of eye diseases and conditions; pharmaceuticals and medicines for the treatment and prevention of bone disorders and conditions; medicated therapeutic preparations for the management of retinal disorders; injectable pharmaceuticals for the treatment of ocular diseases and neurological disorders.ACTIVE—
042Medical and pharmacological research services; pharmaceutical research and development of pharmaceuticals and medicines; pharmaceutical research and development of pharmaceutical products and medicines for the treatment and prevention of neurological disorders, eye diseases and bone disorders.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 9, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 9, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 8, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2026RFNTREFUSAL PROCESSED BY IB—
Mar 6, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 6, 2026RFRRREFUSAL PROCESSED BY MPU—
Feb 5, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 4, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 29, 2026DOCKASSIGNED TO EXAMINER—
Dec 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 29, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance